Figure 2.
Schematic representation of Anti-platelet drugs in use and under development. ASA, acetylsalicylic acid; CVD, cardiovascular disease; PVD, pulmonary vascular disease; CAD, coronary artery disease; MI, myocardial infarction; ACS, acute coronary syndrome; IV, intra veinous; PCI percutaneous coronary intervention.